Where Can I Get Wegovy Injections? Your Comprehensive Guide to Accessing This Innovative Weight Loss Solution

Last reviewed: June 24, 2026

Last updated: June 24, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Wegovy is a prescription medicine, which means there is exactly one legitimate path to it: a prescription from a licensed clinician, filled at a state-licensed pharmacy. The FDA puts it in those words, advising patients to obtain a prescription from their doctor and fill the prescription at a state-licensed pharmacy. What varies is how you reach the prescriber and which pharmacy fills it — an in-person visit and a neighborhood pharmacy, a telehealth consultation and a mail-order or specialty pharmacy, or a manufacturer-run self-pay channel. What does not vary is that no legitimate source ships FDA-approved Wegovy without a prescription, and anything sold that way is something other than what it claims to be.

Start With Whether Wegovy Is the Right Product

Wegovy's labeling has grown considerably, and knowing which indication applies to you shapes the whole access conversation. Per the Wegovy prescribing information, Wegovy injection is indicated, in combination with a reduced-calorie diet and increased physical activity, to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight; to reduce excess body weight and maintain weight reduction long term in adults and pediatric patients aged 12 years and older with obesity, and in adults with overweight plus at least one weight-related comorbid condition; and for the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis with moderate to advanced liver fibrosis in adults, an indication approved under accelerated approval.

There is now also an oral presentation. Wegovy tablets — 1.5 mg, 4 mg, 9 mg and 25 mg — carry two of those indications: cardiovascular risk reduction, and long-term weight reduction in adults with obesity or with overweight plus a weight-related comorbid condition. If injections are the barrier rather than access itself, that is worth raising with a prescriber.

The Prescriber Step Is the Real Bottleneck

Most people who ask where to get Wegovy are really asking how to get a prescription for it. Three routes are common. A primary care clinician or an obesity medicine, endocrinology or cardiology specialist can prescribe it during ordinary care. A telehealth service can connect you to a licensed clinician in your state without an office visit. And in some health systems a weight-management program handles both the evaluation and the prescription.

Whichever route you take, the clinician is assessing the same things: whether you meet a labeled indication, what else you take, and whether anything in your history rules the medication out. Wegovy is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or with Multiple Endocrine Neoplasia syndrome type 2, and in patients with known hypersensitivity to semaglutide or any excipient. The label also notes that concomitant use with other semaglutide-containing products or with any other GLP-1 receptor agonist is not recommended. Those are evaluation questions, not paperwork.

Where the Prescription Gets Filled

Once a prescription exists, dispensing happens at a state-licensed pharmacy. Retail chain and independent pharmacies stock it, though availability of specific strengths varies locally. Mail-order and specialty pharmacies are frequently used for maintenance fills, particularly when a plan routes chronic medications that way. Manufacturers of GLP-1 products have also built self-pay channels that ship directly to patients who have a valid prescription.

One practical note about the dispensing step: the strength you are prescribed changes during the first months of treatment, because the label's escalation schedule moves through several strengths before reaching a maintenance dosage. That means several separate fills, and each one is an opportunity for a supply gap if the pharmacy does not have the next strength on hand. Asking about the next strength at the current fill is a small habit that prevents a common interruption.

Which presentation arrives depends on what was prescribed. The label describes single-dose pens at 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg and 7.2 mg; single-dose syringes at 0.25 mg through 2.4 mg; and a single-patient-use FlexTouch pen containing 9.6 mg/3 mL that delivers four 2.4 mg doses. The label directs that patients be informed which presentation they will receive and be trained on it, and that if the presentation changes they receive appropriate retraining and consult the Instructions for Use for the new one. That training belongs to your pharmacy and prescriber, not to a website.

Cost and Coverage Shape Access as Much as Supply

Coverage for weight-management medications is uneven. Some commercial plans cover Wegovy with prior authorization, some exclude anti-obesity medications entirely, and criteria differ by indication — a plan may treat a cardiovascular risk-reduction prescription differently from a weight-reduction prescription for the same drug.

Practical steps that actually move the needle: ask your plan for its coverage criteria in writing before the first fill, confirm which pharmacies are in network, and ask your prescriber's office whether they handle prior authorizations. If coverage is denied, the appeal pathway and manufacturer self-pay programs are both worth asking about. These are administrative questions with concrete answers, and they are usually the difference between a prescription that gets filled and one that sits.

What to Avoid Entirely

The FDA has warned companies that illegally sold unapproved drugs labeled "for research purposes" or "not for human consumption" while marketing them directly to consumers for human use with dosing instructions. It has also warned about counterfeit versions of GLP-1 products, noting that counterfeit drugs could contain the wrong ingredients, too little, too much or no active ingredient at all, or other harmful ingredients — and are illegal.

The practical filter is simple. If a seller does not require a prescription, does not operate as a licensed pharmacy, ships from an unverifiable address, or describes its product as research material, it is outside the legitimate supply chain. Price is not the tell; the absence of a prescriber and a licensed dispenser is.

Compounded Semaglutide Is Not Wegovy

Compounded semaglutide is prepared by a licensed pharmacy against a prescription for an individual patient. It is not an FDA-approved finished product, and the FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed. It is not a generic version of Wegovy or Ozempic, because neither has an approved generic.

That distinction became sharper after the FDA's semaglutide shortage resolution in 2025 ended the enforcement discretion that had allowed broad compounding of semaglutide copies, with the applicable deadlines falling in April and May of that year. Compounding continues under the conditions the law provides — including preparation for an identified patient pursuant to a valid prescription — and the FDA's own framing is that compounded medications should only be used in patients whose medical needs cannot be met by an FDA-approved drug. If you want Wegovy specifically, ask for Wegovy specifically, and know what you are receiving either way.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

Where can I get Wegovy injections?

Through a prescription from a licensed clinician, filled at a state-licensed pharmacy. The FDA advises patients to obtain a prescription from their doctor and fill it at a state-licensed pharmacy. In practice that means an in-person or telehealth visit to get the prescription, then a retail, mail-order, specialty or manufacturer-operated self-pay pharmacy to dispense it. No legitimate source ships FDA-approved Wegovy without a prescription.

Can I get Wegovy through telehealth?

Yes, provided a licensed clinician in your state evaluates you and determines the medication is appropriate. Telehealth changes how you reach the prescriber, not the requirements. The clinician still assesses whether you meet a labeled indication, reviews your history and other medications, and checks contraindications such as a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 before prescribing.

Is there a pill version of Wegovy?

Yes. Wegovy tablets are available in 1.5 mg, 4 mg, 9 mg and 25 mg strengths. They carry two of Wegovy injection's indications: reducing the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight, and long-term weight reduction in adults with obesity or with overweight plus at least one weight-related comorbid condition. Whether they suit you is a prescriber decision.

How do I know a seller is legitimate?

A legitimate source requires a valid prescription and operates as a licensed pharmacy. The FDA has warned companies that illegally sold unapproved drugs labeled "for research purposes" or "not for human consumption" while marketing them to consumers with dosing instructions, and has warned that counterfeit products may contain the wrong ingredients, the wrong amount, or none at all. No prescription and no licensed dispenser means no legitimacy.

Is compounded semaglutide the same as Wegovy?

No. Compounded semaglutide is not an FDA-approved finished product, and the FDA does not review compounded drugs for safety, effectiveness or quality before marketing. It is prepared by a licensed pharmacy pursuant to a prescription for an individual patient. It is not a generic of Wegovy or Ozempic, since neither has an approved generic, and the FDA's position is that compounded drugs should be used when an approved product cannot meet a patient's needs.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.